Elicio TherapeuticsELTX
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 28 institutions reported holding Elicio Therapeutics Inc. (ELTX) in their 13F filings, up 7 from Q2 2025. 10 opened new positions and 3 sold out. The largest holders were Knoll Capital Management, LLC ($6.9M), Vanguard Group Inc. ($5.2M) and Balyasny Asset Management L.P. ($1.6M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Elicio Therapeutics Inc.
- CUSIP
- 28657F103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $3.8M |
| Exits | 3 | $201K |
All 13F filers, Q2 2025 → Q3 2025: 505,540 shares bought and 45,083 shares sold, net +460,457 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Knoll Capital Management, LLC | 3.70% | No change | 630,915 | $6.9M |
| Vanguard Group Inc. | 0.00% | Add +4.2% | 473,859 | $5.2M |
| Balyasny Asset Management L.P. | 0.00% | New | 148,076 | $1.6M |
| Geode Capital Management, LLC | 0.00% | Add +7.3% | 129,686 | $1.4M |
| Susquehanna International Group, LLP | 0.00% | Add +606.1% | 120,207 | $1.3M |
| Marshall Wace, LLP | 0.00% | New | 86,533 | $947K |
| Northern Trust Corp. | 0.00% | Add +5.1% | 53,584 | $586K |
| Renaissance Technologies | 0.00% | New | 48,671 | $532K |
| BlackRock, Inc. | 0.00% | Add +1.5% | 44,195 | $483K |
| State Street Corp. | 0.00% | Add +77.3% | 38,300 | $419K |
| Cresset Asset Management, LLC | 0.00% | New | 26,925 | $295K |
| Millennium Management | 0.00% | New | 22,846 | $250K |
| Meyer Handelman Co. | 0.00% | No change | 13,899 | $152K |
| Citigroup Inc. | 0.00% | New | 10,658 | $117K |
| Mayflower Financial Advisors, LLC | 0.01% | No change | 10,000 | $109K |
| Moody LYNN Lieberson & Walker, LLC | 0.01% | No change | 10,000 | $109K |
| &partners | 0.00% | No change | 10,000 | $109K |
| UBS Group AG | 0.00% | Add +16.5% | 7,019 | $77K |
| CM Management, LLC | 0.05% | Reduce -76.0% | 6,000 | $66K |
| Jefferies Financial Group Inc. | 0.00% | New | 5,200 | $57K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 7,000 | $43K |
| Bank of America Corp. | 0.00% | Add +186.8% | 3,585 | $39K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 1,554 | $17K |
| Morgan Stanley | 0.00% | Add +304.2% | 1,536 | $17K |
| Farther Finance Advisors, LLC | 0.00% | New | 640 | $7K |
| Wells Fargo & Company | 0.00% | New | 200 | $2K |
| Simplex Trading, LLC | 0.00% | New | 103 | $1K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -1.2% | 82 | $897 |
"% of holder's portfolio" is ELTX's weight in each manager's 13F, not the share of Elicio Therapeutics Inc. the manager owns.